Tanush Gupta
@DrTGupta
Followers
2K
Following
2K
Media
57
Statuses
1K
Interventional/Structural Cardiologist & Associate Cath Lab Director @UVMMedCenter
Burlington, VT
Joined March 2010
Thanks @crfheart for the opportunity to present our work at #NYValves2025. When including all-comer SAVR patients (incl. mechanical valves and concomitant surgery), we report that TAVR only represents ~25% of all AVR for severe AS in <65-year old patients. Full pub link below.
📢 New study presented at #NYValves2025 and published in Structural Heart (@crfshj) highlights key trends in aortic valve replacement for patients under 65 with severe aortic stenosis. @DrTGupta
https://t.co/KnPnK3BbVd
#CardioResearch
2
1
22
Mayra Guerrero - Cardiovascular News https://t.co/sGQwuIPfWw Hard work always pays off. Today was a very special moment as I arrived at the EuroPCR 2025 in Paris and saw that they were handing out this magazine featuring an interview with me, to highlight my professional career
29
36
184
Thank you @ACCinTouch for a fantastic experience over this past year teaching the nuts and bolts of clinical trial research. Priceless learning and friendships!
Congratulations to all of my brilliant and thoughtful colleagues in the 2024-2025 #ACC Clinical Trials Research Cohort for a momentous year! This has truly been a career changing experience! The future is still bright for our field and our patients! https://t.co/6hlouWUxU8
0
0
5
Congratulations @thinkmdkane! It’s a pleasure to work with you.
Check out the latest issue of @cardiacinterv on challenging PCI. Thank you to all of the great authors! -AI in cardiac intervention -complex disease in the geriatric patient -ISR management -delivering equipment and cto techniques in non cto cases -growing in clinical practice
0
0
2
Inoue PBMV can be technically challenging in difficult anatomies. We describe an efficient technique of Inoue PBMV over pre-shaped Safari wire with steps similar to those used for MVIV. Hope readers and other operators find it useful! Full text link: https://t.co/TJwVQVXTql
8
13
67
n=1 but the UNICORN procedure seems to be a game changer in leaflet modification for #TAVR with risk of coronary obstruction @HarryDauerman. Seamless and efficient. @UVMLarnerMed @Medtronic @EdwardsLifesci Thanks to @PedroMDMSc and @kashishgoelmd for the help with planning.
3
4
48
How has the "Heart Team" evolved at your institutions? Read this joint perspective from @ACCinTouch #IC and #surgery councils on this triumphant collaboration in SHD practice. @mirvatalasnag @Pooh_Velagapudi @ChrisMalaisrie @Vetrovec
acc.org
2
4
10
Honored to co-author this @ACCinTouch heart-team consensus document on AS management in younger pts published today in @JACCJournals Interventions: https://t.co/WHcWYNDEqo Congratulations to all co-authors @KendraGrubb @ChrisMalaisrie @_WayneBatchelor @KDBoudoulas @MReardon19
jacc.org
5
6
48
Coronary complications in AMI - part of Complex Cases with the Masters Join us at 4 pm #TCT2024 @TCTConference
@DNFeldmanMD @RajaHatem @DrTGupta
0
2
8
📖Meta-Analysis of 3rd Generation #BalloonExpandable Valves vs. Self-Expanding Valves #TAVR ➡️ https://t.co/xrEEOSAYAs
@DhavalKolte @SammyElmariahMD @HarryDauerman @DrTGupta @KannuBansalMD @sina_kazemia
0
9
22
What are the outcomes of myocardial infarction post #TAVR? Check my interview with @DrTGupta discussing their latest #JACCINT @JACCJournals manuscript 👇🏽 https://t.co/7slZWZE49A
#CardioTwitter #ACCFIT
0
4
22
Fantastic day fostering institutional collaborations in Northern New England and learning from each others’ skill sets. Thanks to @mnyoung1 @jimmydevries for visiting us @uvmvermont from @GeiselMed #cathlab @TAVRBot @HarryDauerman
3
0
34
Great time reconnecting with colleagues and mentors in #nyc @MethodistHosp @HMHCardioFellow @SachinGoelMD @patelapurva @rooshaparikh. Look forward to all the great learning @OPCILive #electrosurgery workshop. @CathElectroSurg
0
2
26
Thank you @ACCinTouch for the opportunity to present and @TCTMD_Yael @ShelleyWood2 @TCTMD for covering the study. In our Northern New England registry analysis, TAVR now utilized in >50% patients with isolated severe AS aged <65 years. @HarryDauerman
“Practice has definitely moved beyond the evidence demonstrated by the low-risk trials and beyond what the guidelines recommend,” @DrTGupta told @TCTMD at #ACC24. https://t.co/03vfZFdIX3
@TCTMD_Yael
0
4
18
🆕📑Presented at #ACC24 💡TAVR is the predominant modality of all AVR for isolated severe AS including pts <65 years old. #TAVR #SAVR #Guidelines #JSCAI Read the findings today: ➡️ https://t.co/VCs9loj9lh
@DrTGupta @HarryDauerman @DeVriesJt @fahadgilanimd
0
15
23
Our analysis of @VizientInc data shows that acute MI events after TAVR are rare. Revascularization rates similar in post-TAVR AMI patients vs. all-comer AMI. Excited to be presenting results at #ACC24 with sim pub in @JACCJournals. Link: https://t.co/guGseWi286
@HarryDauerman
jacc.org
4
2
33
Grateful for this recognition from @SCAI! Look forward to contributing and greater involvement with this important organization. Many thanks to my mentors and colleagues! @UVMLarnerMed @UVMMedCenter
14
3
89